GSK Shares: Analysts Cautious Ahead of Earnings Release - AskTraders.com
AskTraders.comarrow_outwardGSK falls as blood cancer drug likely headed for US rejection
Yahoo.coarrow_outwardGSK takes ยฃ3bn hit after US setback for potential cancer blockbuster
The Timesarrow_outwardFDA staff flags eye safety risks for GSK's blood cancer drug
Reutersarrow_outwardResearch Alert: Fda Panel Rejects Blenrep, Gsk's Share Price Takes A Hit - ๅฏ้็็
ๅฏ้็็arrow_outwardGSK Share Price Falls 6.5% After Blenrep Fails To Secure US Panel Approval - Samco
Samcoarrow_outwardGSK shares slide 6% after US panel rejects key cancer drug combination - Proactive financial news
Proactive financial newsarrow_outwardGSK Stock Drops 6% After FDA Panel Rejects Blood Cancer Drug - AInvest
AInvestarrow_outwardGSK Directors Increase Shareholdings, Signaling Confidence - tipranks.com
Tipranks.comarrow_outwardGSK (GSK) is a Top-Ranked Value Stock: Should You Buy? - Nasdaq
Nasdaqarrow_outwardGSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold? - Yahoo Finance
Yahoo Financearrow_outwardAstraZeneca, GSK shares down after Trump threatens drug import tariffs By Investing.com - Investing.com UK
Investing.com UKarrow_outwardHere's Why GSK (GSK) is a Strong Momentum Stock - sharewise.com
Sharewise.comarrow_outwardBerenberg cuts GlaxoSmithKline stock rating to hold from buy - Investing.com
Investing.comarrow_outwardStock Watch: How GSKโs Nucala Info Drip Helped Share Price - insights.citeline.com
Insights.citeline.comarrow_outwardIs the GSK share price finally getting its act together? - Fool UK
Fool UKarrow_outwardGSK and Astrazeneca shares slump as Trump vows drug price cut - City AM
City AMarrow_outwardWhatโs going on with the GSK share price now? - MSN
MSNarrow_outwardGSK plc (GSK) ORD GBP0.3125 Share Research & Insight - Hargreaves Lansdown
Hargreaves Lansdownarrow_outwardGSK makes strong start to 2025 with growth in sales, profits and earnings - GSK
GSKarrow_outwardCompanies roundup: Barclays, GSK & Melrose - Investors' Chronicle
Investors' Chroniclearrow_outwardGSK Q1 2025 Earnings Preview | Specialty Medicines in Focus - ig.com
Ig.comarrow_outwardGSK share price still low after +6% rise after bullish earnings call - Good Money Guide
Good Money Guidearrow_outwardGSK shares rise 5% as it navigates vaccines woes to upgrade sales target - Proactive Investors
Proactive Investorsarrow_outwardGSK tops FTSE 100 leaderboard on strong Q4, declares ยฃ2 billion share buyback, 5 Feb 2025 11:28 - Shares Magazine
Shares Magazinearrow_outwardDrug firm GSK delivers a syringe full of crowd-pleasers | Nils Pratley - The Guardian
The Guardianarrow_outwardGSK plc's (LON:GSK) Share Price Matching Investor Opinion - simplywall.st
Simplywall.starrow_outwardStockwatch: a better 2025 for GSK, or best to sell now? - Interactive Investor
Interactive Investorarrow_outwardGSK share price surges after $2.2bn Zantac drug settlement - MoneyWeek
MoneyWeekarrow_outwardGSK shares jump after drugmaker reaches $2.2bn Zantac settlement - Financial Times
Financial Timesarrow_outwardFTSE 100 Live 10 October: GSK shares rise on $2.2bn Zantac settlement, property firm gets ยฃ1.1bn bid - London Evening Standard
London Evening Standardarrow_outward
Gsk Share Price close
- 2025-07-21 15:20 event
- 31 sourceslanguage
- 200+ ads_click
- 1 month ago schedule